Literature DB >> 25892335

Global insights into alternative polyadenylation regulation.

Ranjan Batra1, Mini Manchanda, Maurice S Swanson.   

Abstract

Alternative pre-mRNA processing greatly increases the coding capacity of the human genome and regulatory factors involved in RNA processing play critical roles in tissue development and maintenance. Indeed, abnormal functions of RNA processing factors have been associated with a wide range of human diseases from cancer to neurodegenerative disorders. While many studies have emphasized the importance of alternative splicing (AS), recent high-throughput sequencing efforts have also allowed global surveys of alternative polyadenylation (APA). For the majority of pre-mRNAs, as well as some non-coding transcripts such as lncRNAs, APA selects different 3'-ends and thus modulates the availability of regulatory sites recognized by trans-acting regulatory effectors, including miRs and RNA binding proteins (RBPs). Here, we compare the available technologies for assessing global polyadenylation patterns, summarize the roles of auxiliary factors on APA, and discuss the impact of differential polyA site (pA) selection in the determination of cell fate, transformation and disease.

Entities:  

Keywords:  3′ UTR, 3′-untranslated region; APA, Alternative polyadenylation; AS, Alternative splicing; DM, Myotonic dystrophy; HITS-CLIP, High-throughput sequencing coupled with crosslinking and immunoprecipitation; KD, Knockdown; KO, Knockout; MBNL; PolyA-seq; RBP, RNA binding protein; RNA processing; alternative polyadenylation; microsatellites; myotonic dystrophy; neurological disease; pA, Polyadenylation site

Mesh:

Substances:

Year:  2015        PMID: 25892335      PMCID: PMC4615881          DOI: 10.1080/15476286.2015.1040974

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  53 in total

1.  Identification and characterization of polyadenylation signal (PAS) variants in human genomic sequences based on modified EST clustering.

Authors:  Masami Kamasawa; Jun-ichi Horiuchi
Journal:  In Silico Biol       Date:  2008

2.  RNA polymerase II kinetics in polo polyadenylation signal selection.

Authors:  Pedro A B Pinto; Telmo Henriques; Marta O Freitas; Torcato Martins; Rita G Domingues; Paulina S Wyrzykowska; Paula A Coelho; Alexandre M Carmo; Claudio E Sunkel; Nicholas J Proudfoot; Alexandra Moreira
Journal:  EMBO J       Date:  2011-05-20       Impact factor: 11.598

3.  Complex and dynamic landscape of RNA polyadenylation revealed by PAS-Seq.

Authors:  Peter J Shepard; Eun-A Choi; Jente Lu; Lisa A Flanagan; Klemens J Hertel; Yongsheng Shi
Journal:  RNA       Date:  2011-02-22       Impact factor: 4.942

Review 4.  Mechanisms and consequences of alternative polyadenylation.

Authors:  Dafne Campigli Di Giammartino; Kensei Nishida; James L Manley
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

5.  Hu proteins regulate polyadenylation by blocking sites containing U-rich sequences.

Authors:  Hui Zhu; Hua-Lin Zhou; Robert A Hasman; Hua Lou
Journal:  J Biol Chem       Date:  2006-11-26       Impact factor: 5.157

6.  Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43.

Authors:  Magdalini Polymenidou; Clotilde Lagier-Tourenne; Kasey R Hutt; Stephanie C Huelga; Jacqueline Moran; Tiffany Y Liang; Shuo-Chien Ling; Eveline Sun; Edward Wancewicz; Curt Mazur; Holly Kordasiewicz; Yalda Sedaghat; John Paul Donohue; Lily Shiue; C Frank Bennett; Gene W Yeo; Don W Cleveland
Journal:  Nat Neurosci       Date:  2011-02-27       Impact factor: 24.884

7.  Characterizing the RNA targets and position-dependent splicing regulation by TDP-43.

Authors:  James R Tollervey; Tomaž Curk; Boris Rogelj; Michael Briese; Matteo Cereda; Melis Kayikci; Julian König; Tibor Hortobágyi; Agnes L Nishimura; Vera Zupunski; Rickie Patani; Siddharthan Chandran; Gregor Rot; Blaž Zupan; Christopher E Shaw; Jernej Ule
Journal:  Nat Neurosci       Date:  2011-02-27       Impact factor: 24.884

8.  Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons.

Authors:  Juan Ji An; Kusumika Gharami; Guey-Ying Liao; Newton H Woo; Anthony G Lau; Filip Vanevski; Enrique R Torre; Kevin R Jones; Yue Feng; Bai Lu; Baoji Xu
Journal:  Cell       Date:  2008-07-11       Impact factor: 41.582

9.  Polypyrimidine tract binding protein modulates efficiency of polyadenylation.

Authors:  Pedro Castelo-Branco; Andre Furger; Matthew Wollerton; Christopher Smith; Alexandra Moreira; Nick Proudfoot
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  HITS-CLIP yields genome-wide insights into brain alternative RNA processing.

Authors:  Donny D Licatalosi; Aldo Mele; John J Fak; Jernej Ule; Melis Kayikci; Sung Wook Chi; Tyson A Clark; Anthony C Schweitzer; John E Blume; Xuning Wang; Jennifer C Darnell; Robert B Darnell
Journal:  Nature       Date:  2008-11-02       Impact factor: 49.962

View more
  13 in total

1.  Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9.

Authors:  Ranjan Batra; David A Nelles; Elaine Pirie; Steven M Blue; Ryan J Marina; Harrison Wang; Isaac A Chaim; James D Thomas; Nigel Zhang; Vu Nguyen; Stefan Aigner; Sebastian Markmiller; Guangbin Xia; Kevin D Corbett; Maurice S Swanson; Gene W Yeo
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

2.  Altered Expression of MBNL Family of Alternative Splicing Factors in Colorectal Cancer.

Authors:  Nazila Navvabi; Pavla Kolikova; Petr Hosek; Frantisek Zitricky; Azita Navvabi; Ondrej Vycital; Jan Bruha; Richard Palek; Jachym Rosendorf; Vaclav Liska; Pavel Pitule
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

3.  MBNL splicing activity depends on RNA binding site structural context.

Authors:  Katarzyna Taylor; Lukasz J Sznajder; Piotr Cywoniuk; James D Thomas; Maurice S Swanson; Krzysztof Sobczak
Journal:  Nucleic Acids Res       Date:  2018-09-28       Impact factor: 16.971

4.  Deprivation of Muscleblind-Like Proteins Causes Deficits in Cortical Neuron Distribution and Morphological Changes in Dendritic Spines and Postsynaptic Densities.

Authors:  Kuang-Yung Lee; Ho-Ching Chang; Carol Seah; Li-Jen Lee
Journal:  Front Neuroanat       Date:  2019-07-30       Impact factor: 3.856

5.  The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1.

Authors:  Ranjan Batra; David A Nelles; Daniela M Roth; Florian Krach; Curtis A Nutter; Takahiro Tadokoro; James D Thomas; Łukasz J Sznajder; Steven M Blue; Haydee L Gutierrez; Patrick Liu; Stefan Aigner; Oleksandr Platoshyn; Atsushi Miyanohara; Martin Marsala; Maurice S Swanson; Gene W Yeo
Journal:  Nat Biomed Eng       Date:  2020-09-14       Impact factor: 25.671

6.  RNA-binding protein CPEB1 remodels host and viral RNA landscapes.

Authors:  Ranjan Batra; Thomas J Stark; Alex E. Clark; Jean-Philippe Belzile; Emily C Wheeler; Brian A Yee; Hui Huang; Chelsea Gelboin-Burkhart; Stephanie C Huelga; Stefan Aigner; Brett T Roberts; Tomas J Bos; Shashank Sathe; John Paul Donohue; Frank Rigo; Manuel Ares; Deborah H Spector; Gene W Yeo
Journal:  Nat Struct Mol Biol       Date:  2016-10-24       Impact factor: 18.361

Review 7.  Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.

Authors:  Laurène M André; C Rosanne M Ausems; Derick G Wansink; Bé Wieringa
Journal:  Front Neurol       Date:  2018-05-28       Impact factor: 4.003

8.  Poly(A)-seq: A method for direct sequencing and analysis of the transcriptomic poly(A)-tails.

Authors:  Fengyun Yu; Yu Zhang; Chao Cheng; Wenqing Wang; Zisong Zhou; Wenliang Rang; Han Yu; Yaxun Wei; Qijia Wu; Yi Zhang
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240

Review 9.  MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy.

Authors:  Arturo López Castel; Sarah Joann Overby; Rubén Artero
Journal:  Int J Mol Sci       Date:  2019-11-09       Impact factor: 5.923

10.  Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy.

Authors:  Estefanía Cerro-Herreros; Irene González-Martínez; Nerea Moreno-Cervera; Sarah Overby; Manuel Pérez-Alonso; Beatriz Llamusí; Rubén Artero
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-21       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.